Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

CAPRICOR THERAPEUTICS, INC. Operating Cash Flow

CAPRICOR THERAPEUTICS, INC. (CAPR) reported Operating Cash Flow of -$60.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14

  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$31.49M.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$29.25M.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$23.57M.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$19.69M.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$69.81M.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$40.00M.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$25.60M, a 620.61% decline from fiscal 2022.
  • CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $4.92M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 71 monthNet Cash Provided by (Used in) Operating Activities 74 monthNet Cash Provided by (Used in) Operating Activities 77 monthNet Cash Provided by (Used in) Operating Activities 80 monthNet Cash Provided by (Used in) Operating Activities 83 monthNet Cash Provided by (Used in) Operating Activities 86 monthNet Cash Provided by (Used in) Operating Activities 89 monthNet Cash Provided by (Used in) Operating Activities 92 monthNet Cash Provided by (Used in) Operating Activities 95 monthNet Cash Provided by (Used in) Operating Activities 98 month
2026-06-30-$31.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$60.74M
10-Q · filed 2026-08-14
-$84.31M
derived: sum of 3 quarters · filed 2026-08-14
-$104.00M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31-$29.25M
10-Q · filed 2026-05-13
-$52.82M
derived: sum of 2 quarters · filed 2026-05-13
-$72.51M
derived: sum of 3 quarters · filed 2026-05-13
-$92.63M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$23.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
-$43.26M
derived: sum of 2 quarters · filed 2026-03-17
-$63.38M
derived: sum of 3 quarters · filed 2026-08-14
-$69.81M
10-K · filed 2026-03-17
2025-09-30-$19.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$39.81M
derived: sum of 2 quarters · filed 2026-08-14
-$46.24M
10-Q · filed 2025-11-10
-$61.04M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$20.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$26.56M
10-Q · filed 2026-08-14
-$41.35M
derived: sum of 3 quarters · filed 2026-08-14
-$52.99M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$6.43M
10-Q · filed 2026-05-13
-$21.23M
derived: sum of 2 quarters · filed 2026-05-13
-$32.87M
derived: sum of 3 quarters · filed 2026-05-13
-$45.16M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$14.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
-$26.44M
derived: sum of 2 quarters · filed 2026-03-17
-$38.73M
derived: sum of 3 quarters · filed 2026-03-17
-$40.00M
10-K · filed 2026-03-17
2024-09-30-$11.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
-$23.93M
derived: sum of 2 quarters · filed 2025-11-10
-$25.20M
10-Q · filed 2025-11-10
-$36.79M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$12.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$13.56M
10-Q · filed 2025-08-11
-$25.15M
derived: sum of 3 quarters · filed 2025-08-11
-$33.95M
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31-$1.27M
10-Q · filed 2025-05-14
-$12.86M
derived: sum of 2 quarters · filed 2025-05-14
-$21.66M
derived: sum of 3 quarters · filed 2025-05-14
-$31.08M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$11.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
-$20.39M
derived: sum of 2 quarters · filed 2025-03-26
-$29.81M
derived: sum of 3 quarters · filed 2025-03-26
-$25.60M
10-K · filed 2025-03-26
2023-09-30-$8.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$18.21M
derived: sum of 2 quarters · filed 2024-11-14
-$14.00M
10-Q · filed 2024-11-14
-$20.90M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$9.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$5.21M
10-Q · filed 2024-08-08
-$12.11M
derived: sum of 3 quarters · filed 2024-08-08
-$17.80M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$4.21M
10-Q · filed 2024-05-14
-$2.69M
derived: sum of 2 quarters · filed 2024-05-14
-$8.38M
derived: sum of 3 quarters · filed 2024-05-14
-$14.92M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$6.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11
-$12.59M
derived: sum of 2 quarters · filed 2024-03-11
-$19.13M
derived: sum of 3 quarters · filed 2024-03-11
$4.92M
10-K · filed 2024-03-11
2022-09-30-$5.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$12.23M
derived: sum of 2 quarters · filed 2023-11-14
$11.82M
10-Q · filed 2023-11-14
$6.19M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$6.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$17.50M
10-Q · filed 2023-08-08
$11.88M
derived: sum of 3 quarters · filed 2023-08-08
$8.54M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$24.05M
10-Q · filed 2023-05-12
$18.42M
derived: sum of 2 quarters · filed 2023-05-12
$15.08M
derived: sum of 3 quarters · filed 2023-05-12
$10.57M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$5.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17
-$8.97M
derived: sum of 2 quarters · filed 2023-03-17
-$13.48M
derived: sum of 3 quarters · filed 2023-03-17
-$16.81M
10-K · filed 2023-03-17
2021-09-30-$3.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$7.85M
derived: sum of 2 quarters · filed 2022-11-10
-$11.18M
10-Q · filed 2022-11-10
-$15.02M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$4.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
-$7.84M
10-Q · filed 2022-08-12
-$11.69M
derived: sum of 3 quarters · filed 2022-08-12
-$14.66M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31-$3.33M
10-Q · filed 2022-05-11
-$7.17M
derived: sum of 2 quarters · filed 2022-05-11
-$10.15M
derived: sum of 3 quarters · filed 2022-05-11
-$12.17M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31-$3.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
-$6.82M
derived: sum of 2 quarters · filed 2022-03-11
-$8.84M
derived: sum of 3 quarters · filed 2022-03-11
-$10.05M
10-K · filed 2022-03-11
2020-09-30-$2.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$4.99M
derived: sum of 2 quarters · filed 2021-11-12
-$6.21M
10-Q · filed 2021-11-12
-$8.00M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$2.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
-$3.23M
10-Q · filed 2021-08-13
-$5.02M
derived: sum of 3 quarters · filed 2021-08-13
-$6.67M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$1.22M
10-Q · filed 2021-05-14
-$3.00M
derived: sum of 2 quarters · filed 2021-05-14
-$4.65M
derived: sum of 3 quarters · filed 2021-05-14
-$6.43M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$1.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
-$3.44M
derived: sum of 2 quarters · filed 2021-03-15
-$5.21M
derived: sum of 3 quarters · filed 2021-03-15
-$6.82M
10-K · filed 2021-03-15
2019-09-30-$1.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
-$3.43M
derived: sum of 2 quarters · filed 2020-11-13
-$5.04M
10-Q · filed 2020-11-13
-$8.81M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30-$1.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$3.39M
10-Q · filed 2020-08-10
-$7.16M
derived: sum of 3 quarters · filed 2020-08-10
-$10.14M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31-$1.61M
10-Q · filed 2020-05-15
-$5.38M
derived: sum of 2 quarters · filed 2020-05-15
-$8.36M
derived: sum of 3 quarters · filed 2020-05-15
-$12.05M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27
-$6.75M
derived: sum of 2 quarters · filed 2020-03-27
-$10.44M
derived: sum of 3 quarters · filed 2020-03-27
-$13.86M
10-K · filed 2020-03-27
2018-09-30-$2.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$6.67M
derived: sum of 2 quarters · filed 2019-11-08
-$10.09M
10-Q · filed 2019-11-08
-$10.09M
10-Q · filed 2018-11-14
-$12.76M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30-$3.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$7.11M
10-Q · filed 2019-08-08
-$9.78M
derived: sum of 3 quarters · filed 2019-08-08
-$12.97M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$3.42M
10-Q · filed 2019-05-14
-$6.09M
derived: sum of 2 quarters · filed 2019-05-14
-$9.27M
derived: sum of 3 quarters · filed 2019-05-14
-$12.97M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$2.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
-$5.86M
derived: sum of 2 quarters · filed 2019-03-29
-$9.55M
derived: sum of 3 quarters · filed 2019-03-29
-$14.23M
10-K · filed 2019-03-29
2017-09-30-$3.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$6.89M
derived: sum of 2 quarters · filed 2018-11-14
-$11.56M
10-Q · filed 2018-11-14
-$15.04M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$3.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
-$8.37M
10-Q · filed 2018-08-13
-$11.85M
derived: sum of 3 quarters · filed 2018-08-13
2017-03-31-$4.68M
10-Q · filed 2018-05-14
-$8.15M
derived: sum of 2 quarters · filed 2018-05-14
2016-12-31-$3.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$14.45M
10-K · filed 2018-03-22
2016-09-30-$10.98M
10-Q · filed 2017-11-14
2013-09-30-$158.18K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$214.00K
derived: sum of 2 quarters · filed 2013-11-14
-$358.19K
10-Q · filed 2013-11-14
-$593.98K
derived: sum of 4 quarters · filed 2013-11-14
-$35.25M
10-Q · filed 2013-11-14
2013-06-30-$55.83K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$200.01K
10-Q · filed 2013-08-14
-$435.80K
derived: sum of 3 quarters · filed 2013-08-14
-$930.48K
derived: sum of 4 quarters · filed 2013-11-14
-$35.09M
10-Q · filed 2013-08-14
2013-03-31-$144.18K
10-Q · filed 2013-06-21
-$379.98K
derived: sum of 2 quarters · filed 2013-06-21
-$874.65K
derived: sum of 3 quarters · filed 2013-11-14
-$1.73M
derived: sum of 4 quarters · filed 2013-11-14
-$35.04M
10-Q · filed 2013-06-21
2012-12-31-$235.79K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21
-$730.47K
derived: sum of 2 quarters · filed 2013-11-14
-$1.58M
derived: sum of 3 quarters · filed 2013-11-14
-$2.19M
10-K · filed 2013-06-21
-$34.89M
10-K · filed 2013-06-21
2012-09-30-$494.68K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14
-$1.35M
derived: sum of 2 quarters · filed 2013-11-14
-$1.95M
10-Q · filed 2013-11-14
-$3.52M
derived: sum of 4 quarters · filed 2013-11-14
-$34.66M
10-Q · filed 2013-06-21
2012-06-30-$852.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$1.46M
10-Q · filed 2013-08-14
-$3.02M
derived: sum of 3 quarters · filed 2013-08-14
-$3.68M
derived: sum of 4 quarters · filed 2013-08-14
-$34.16M
10-Q/A · filed 2012-09-10
2012-03-31-$603.46K
10-Q · filed 2013-06-21
-$2.17M
derived: sum of 2 quarters · filed 2013-06-21
-$2.82M
derived: sum of 3 quarters · filed 2013-06-21
-$3.99M
derived: sum of 4 quarters · filed 2013-06-21
-$33.31M
10-Q · filed 2012-05-15
2011-12-31-$1.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21
-$2.22M
derived: sum of 2 quarters · filed 2013-06-21
-$3.39M
derived: sum of 3 quarters · filed 2013-06-21
-$4.65M
10-K · filed 2013-06-21
-$32.70M
10-K · filed 2012-04-02
2011-09-30-$652.50K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21
-$1.82M
derived: sum of 2 quarters · filed 2013-06-21
-$3.08M
10-Q · filed 2013-06-21
-$4.14M
derived: sum of 4 quarters · filed 2013-06-21
-$31.14M
10-Q · filed 2011-11-14
2011-06-30-$1.17M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10
-$2.43M
10-Q/A · filed 2012-09-10
-$3.48M
derived: sum of 3 quarters · filed 2012-09-10
-$4.62M
derived: sum of 4 quarters · filed 2012-09-10
-$30.48M
10-Q · filed 2011-08-15
2011-03-31-$1.26M
10-Q · filed 2012-05-15
-$2.32M
derived: sum of 2 quarters · filed 2012-05-15
-$3.45M
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31-$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02
-$2.19M
derived: sum of 2 quarters · filed 2012-04-02
-$4.32M
10-K · filed 2012-04-02
2010-09-30-$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$3.26M
10-Q · filed 2011-11-14
2010-06-30-$2.13M
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63